Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics

被引：0

作者：

Abdallah Fayssoil

Olivier Nardi

David Orlikowski

Djillali Annane

机构：

[1] University of Medicine and Dentistry of New Jersey,Intensive Care Unit

[2] Raymond Poincaré Hospital,undefined

[3] AP-HP,undefined

来源：

Heart Failure Reviews | 2010年 / 15卷

关键词：

Duchenne; Dystrophin; Heart failure; ACE inhibitors; Beta-blockers; Experimental therapies;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder caused by the absence of dystrophin, a sarcolemmal protein which links the cytoskeleton to the extracellular matrix by interacting with a large number of proteins. Heart failure is a classic complication of this disease. The authors review the pathogenesis and therapeutics of cardiac involvement in DMD.

引用

收藏

页码：103 / 107

页数：4

相关论文

共 50 条

[21] New and emerging pharmacotherapy for duchenne muscular dystrophy: a focus on synthetic therapeutics [J].

Grages, Sharon M. ;

Bell, Michael ;

Berlau, Daniel J. .

EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (07) :841-851

[22] Duchenne muscular dystrophy [J].

Yiu, Eppie M. ;

Kornberg, Andrew J. .

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2015, 51 (08) :759-764

[23] Duchenne muscular dystrophy [J].

von Moers, A. .

NERVENHEILKUNDE, 2011, 30 (10) :805-+

[24] Cardiac MRI Derived Ti Times in Cardiomyopathy Associated with Duchenne Muscular Dystrophy are Abnormal [J].

Soslow, Jonathan H. ;

Damon, Bruce M. ;

Parra, David A. ;

Burnette, W. B. ;

Wang, Wenli ;

Markham, Larry W. .

CIRCULATION, 2012, 126 (21)

[25] Altered myofilament structure and function in dogs with Duchenne muscular dystrophy cardiomyopathy [J].

Mou, Younss Ait ;

Lacampagne, Alain ;

Irving, Thomas ;

Scheuermann, Valerie ;

Blot, Stephane ;

Ghaleh, Bijan ;

de Tombe, Pieter P. ;

Cazorla, Olivier .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 114 :345-353

[26] Ivabradine ameliorates cardiomyopathy progression in a Duchenne muscular dystrophy model rat [J].

Tochinai, Ryota ;

Kimura, Koichi ;

Saika, Takeru ;

Fujii, Wataru ;

Morita, Hiroyuki ;

Nakanishi, Koki ;

Tsuru, Yoshiharu ;

Sekizawa, Shin-ichi ;

Yamanouchi, Keitaro ;

Kuwahara, Masayoshi .

EXPERIMENTAL ANIMALS, 2024, 73 (02) :145-153

[27] Gene Therapy for Duchenne Muscular Dystrophy [J].

Elangkovan, Nertiyan ;

Dickson, George .

JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 :S303-S316

[28] Current Understanding of Molecular Pathology and Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy [J].

van Westering, Tirsa L. E. ;

Betts, Corinne A. ;

Wood, Matthew J. A. .

MOLECULES, 2015, 20 (05) :8823-8855

[29] Cardiomyopathy as cause of death in Duchenne muscular dystrophy: a longitudinal observational study [J].

Lechner, Annabel ;

Herzig, Joel J. ;

Kientsch, Jacqueline G. ;

Kohler, Malcolm ;

Bloch, Konrad E. ;

Ulrich, Silvia ;

Schwarz, Esther I. .

ERJ OPEN RESEARCH, 2023, 9 (05)

[30] Predictors of Death in Adults With Duchenne Muscular Dystrophy-Associated Cardiomyopathy [J].

Cheeran, Daniel ;

Khan, Shaida ;

Khera, Rohan ;

Bhatt, Anish ;

Garg, Sonia ;

Grodin, Justin L. ;

Morlend, Robert ;

Araj, Faris G. ;

Amin, Alpesh A. ;

Thibodeau, Jennifer T. ;

Das, Sandeep ;

Drazner, Mark H. ;

Mammen, Pradeep P. A. .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (10)

← 1 2 3 4 5 →